Laura Bellingacci
Perugia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Multiple sclerosis synaptic connectome: Insights from fluid biomarkers.
Journal: Neural regeneration research
Published: August 08, 2025
Advances in gene therapy for Lafora disease: Intravenous recombinant adeno-associated virus-mediated delivery of EPM2A and EPM2B genes.
Journal: Clinical and translational medicine
Published: July 01, 2025
Neuronal hyperexcitability: A key to unraveling hippocampal synaptic dysfunction in Lafora disease.
Journal: Epilepsia
Published: June 23, 2025
Immune control of the basal ganglia network: Interleukin-17 as a key modulator of striatal synaptic plasticity.
Journal: Neurobiology of disease
Published: February 02, 2025
Oligomeric alpha-synuclein causes early synaptic dysfunction of the corticostriatal pathway associated with non-motor symptoms.
Journal: NPJ Parkinson's disease
Published: January 14, 2025
Enhancing sleep quality in synucleinopathies through physical exercise.
Journal: Frontiers in cellular neuroscience
Published: October 23, 2024
Cerebrospinal fluid interferon-γ and development of depression in multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: August 04, 2024
Locally Synthetized 17-β-Estradiol Reverses Amyloid-β-42-Induced Hippocampal Long-Term Potentiation Deficits.
Journal: International journal of molecular sciences
Published: January 01, 2024
Gene therapy for Lafora disease in the Epm2a-/- mouse model.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 22, 2023
Cytokines, synaptic plasticity and network dynamics: a matter of balance.
Journal: Neural regeneration research
Published: July 14, 2023
Cerebrospinal fluid, brain, and spinal cord levels of L-aspartate signal excitatory neurotransmission abnormalities in multiple sclerosis patients and experimental autoimmune encephalomyelitis mouse model.
Journal: Journal of neurochemistry
Published: February 21, 2023
Non-competitive AMPA glutamate receptors antagonism by perampanel as a strategy to counteract hippocampal hyper-excitability and cognitive deficits in cerebral amyloidosis.
Journal: Neuropharmacology
Published: June 25, 2022
Last Updated: 09/26/2026